Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Invested Capital (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Invested Capital readings, the most recent being $89.1 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 21.1% to $89.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.1 million, a 21.1% decrease, with the full-year FY2025 number at $89.1 million, down 21.1% from a year prior.
  • Invested Capital hit $89.1 million in Q4 2025 for Treace Medical Concepts, down from $91.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $157.6 million in Q1 2023 to a low of $28.5 million in Q1 2021.
  • Median Invested Capital over the past 5 years was $100.8 million (2021), compared with a mean of $101.4 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 130167.09% in 2021 and later crashed 36.12% in 2022.
  • Treace Medical Concepts' Invested Capital stood at $93.1 million in 2021, then tumbled by 34.97% to $60.5 million in 2022, then skyrocketed by 127.89% to $137.9 million in 2023, then decreased by 18.16% to $112.9 million in 2024, then dropped by 21.1% to $89.1 million in 2025.
  • The last three reported values for Invested Capital were $89.1 million (Q4 2025), $91.0 million (Q3 2025), and $98.7 million (Q2 2025) per Business Quant data.